Ciclopirox NDC 45802-141

NDC codes

FDA NDC Directory

Product NDC (as listed)45802-141Labeler and product segments. Claims need a package NDC.

Product NDC at billing width45802-0141Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
45802-141-67	45802014167	1 BOTTLE, WITH APPLICATOR in 1 CARTON (45802-141-67) / 6.6 mL in 1 BOTTLE, WITH APPLICATORMarketed from Sep 19, 2007

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ciclopirox
Generic name (nonproprietary): ciclopirox
Active ingredients: Ciclopirox — 80 mg/mL
Dosage form: Solution
Route: Topical
Labeler: Padagis Israel Pharmaceuticals Ltd
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077623
Marketing start: Sep 19, 2007
Listing expires: Dec 31, 2026
Other FDA classes: Decreased DNA Replication (Physiologic effect)Decreased Protein Synthesis (Physiologic effect)Decreased RNA Replication (Physiologic effect)Protein Synthesis Inhibitors (Mechanism)
Identifiers: Product ID 45802-141_d75239bb-7620-45a8-9c3b-a41e4baa48dcSPL ID d75239bb-7620-45a8-9c3b-a41e4baa48dcSPL set ID 02f46b6e-b424-4210-83bf-e79618df4344RxCUI 309291UNII 19W019ZDRJ

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N445802014167 followed by a unit qualifier and the quantity

Package 45802-0141-67. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 24, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE (To understand fully the indication for this product, please read the entire INDICATIONS AND USAGE section of the labeling.) Ciclopirox Topical Solution, 8% as a component of a comprehensive management program, is indicated as topical treatment in immunocompetent patients with mild to moderate onychomycosis of fingernails and toenails without lunula involvement, due to Trichophyton rubrum . The comprehensive management program includes removal of the unattached, infected nails as frequently as monthly, by a health care professional who has special competence in the diagnosis and treatment of nail disorders, including minor nail procedures. • No studies have been conduct…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077623

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077623
Product	Strength	Form · route	Labeler	Product NDC
Ciclopirox	Ciclopirox 80 mg/mL	SolutionTopical	Preferred Pharmaceuticals, Inc.	68788-6797
Ciclopirox	Ciclopirox 80 mg/mL	SolutionTopical	Bryant Ranch Prepack	63629-8623
Ciclopirox	Ciclopirox 80 mg/mL	SolutionTopical	Bryant Ranch Prepack	72162-2076